PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:56 AM ET

Sponsor Check › Person

HE
No photo found yet (own website and image search run after this page is viewed)

Henry Esber

Named as an officer, director or promoter on SEC Form D filings · CA · Mar 23, 2012 → Jan 11, 2019

2deals (issuers)
$8.48Mreported sold
41investors
18Form D filings
2012–2019years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Henry Esber is listed as an executive officer and director on 18 SEC Form D filings by 2 issuers between Mar 2010 and Jan 2019: INNOVUS PHARMACEUTICALS, INC. (San Diego, CA — pharmaceuticals — 2012–2019; $4.48M reported sold to 28 investors) and SEELOS THERAPEUTICS, INC. (New York, NY — biotechnology — 2010; $4M reported sold to 13 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $8.48M sold in total.

Listed alongside Vivian Liu (18 shared filings), Bassam Damaj (16 shared filings), Ziad Mirza (15 shared filings), Morgan Reed Brown (7 shared filings), Edward Cox (2 shared filings) and 9 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Henry. Each name links to their own page.

1 of the issuers belongs to the sponsor group Innovus (3 issuers, $3.54M reported sold, 2012–2019).

What this means A sponsor group is one team that sets up a new company for each deal. Innovus has 3 companies on file and $3.54M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 18 public filings for Henry Esber and found 12 differences, 1 worth asking the sponsor about: 7 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Henry Esber has not run yet — it is joining a line of 29,145 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Henry Esber..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Henry Esber — 1 worth asking about (compared 18 filings on Oct 24, 2026)

Note · Jan 6, 1997 – Nov 16, 2024

4 bankruptcy cases name the subject or team members

Bankruptcy case: SEELOS THERAPEUTICS, INC. — filed Nov 16, 2024 · Bankruptcy case: NextGear Capital, Inc. v. Nuhaily — filed Mar 29, 2021 · Bankruptcy case: Rusty P Ray — filed Feb 2, 2011 · Bankruptcy case: Rusty P. Ray and Shannon L. Ray — filed Jan 6, 1997

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. New York ↗SEELOS THERAPEUTICS, INC. — PartnerFacts page ↗Docket · United States Bankruptcy Court, S.D. California ↗Dean Nuhaily — PartnerFacts page ↗
Sources
Worth asking · Feb 4, 2010 – Aug 28, 2013

7 Form Ds were filed more than 15 days after the first sale

Form D filed 630 days after the first sale — INNOVUS PHARMACEUTICALS, INC. · Form D filed 593 days after the first sale — INNOVUS PHARMACEUTICALS, INC. · Form D filed 225 days after the first sale — INNOVUS PHARMACEUTICALS, INC. · Form D filed 630 days after the first sale — INNOVUS PHARMACEUTICALS, INC. · Form D filed 192 days after the first sale — INNOVUS PHARMACEUTICALS, INC. · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Aug 28, 2013 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗Form D · Aug 28, 2013 ↗Form D · Aug 28, 2013 ↗
Sources
Note · Aug 3, 2015 – Aug 6, 2015

No amendment in the last 12 months on an offering that may still be open — INNOVUS PHARMACEUTICALS, INC. (latest filing Aug 6, 2015)

The latest filing for this offering is dated Aug 6, 2015 (first sale Aug 3, 2015). It reports $500,000 sold of $1,500,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Aug 6, 2015 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Dec 24, 2013 – Jan 7, 2014

No amendment in the last 12 months on an offering that may still be open — INNOVUS PHARMACEUTICALS, INC. (latest filing Jan 7, 2014)

The latest filing for this offering is dated Jan 7, 2014 (first sale Dec 24, 2013). It reports $0 sold of an indefinite amount offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Jan 7, 2014 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Feb 15, 2013 – Aug 26, 2013

No amendment in the last 12 months on an offering that may still be open — INNOVUS PHARMACEUTICALS, INC. (latest filing Aug 26, 2013)

The latest filing for this offering is dated Aug 26, 2013 (first sale Feb 15, 2013). It reports $4,484,661 sold of $6,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Aug 26, 2013 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Mar 10, 2010 – Mar 18, 2010

Offering amount changed between filings — SEELOS THERAPEUTICS, INC.

The Mar 10, 2010 filing says $2,500,000 offered; the Mar 18, 2010 Form D says $4,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Mar 10, 2010 ↗Form D (later) · Mar 18, 2010 ↗SEELOS THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Mar 10, 2010 – Mar 23, 2012

Henry Esber is written 2 different ways on the filings

listed as "Henry J. Esber" on 2 filings (from Mar 10, 2010), and "Henry Esber" on 16 filings (from Mar 23, 2012).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Mar 10, 2010 ↗Form D · Mar 23, 2012 ↗Henry Esber — PartnerFacts page ↗
Sources
Note · Mar 23, 2012 – Jan 11, 2019

Reported revenue range changed between filings — INNOVUS PHARMACEUTICALS, INC.

"No Revenues" (Mar 23, 2012); then "Decline to Disclose" (Aug 26, 2013); then "$1 - $1,000,000" (Jan 7, 2014); then "Decline to Disclose" (Feb 25, 2014); then "$5,000,001 - $25,000,000" (Jan 11, 2019).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Mar 23, 2012 ↗Form D · Aug 26, 2013 ↗Form D · Jan 7, 2014 ↗Form D · Feb 25, 2014 ↗
Sources
Note · Jun 16, 2017 – Nov 5, 2019

Same name, different state: "Henry J. Esber" (NH or MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Henry J. Esber" with address state NH or MA, is listed on 5 filings — most recently by BIOXYTRAN, INC (Nov 5, 2019). Both records have filings in the same period (Jun 16, 2017 to Jan 11, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Henry J. Esber (NH,MA) — PartnerFacts page ↗Form D · Nov 5, 2019 ↗BIOXYTRAN, INC — PartnerFacts page ↗Henry Esber (CA) — this page ↗
Sources
Note · Nov 16, 2015 – Sep 5, 2017

Same name, different state: "Henry Esber" (MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Henry Esber" with address state MA, is listed on 2 filings — most recently by General Oncology, Inc. (Sep 5, 2017). Both records have filings in the same period (Nov 16, 2015 to Sep 5, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Henry Esber (MA) — PartnerFacts page ↗Form D/A · Sep 5, 2017 ↗General Oncology, Inc. — PartnerFacts page ↗Henry Esber (CA) — this page ↗
Sources
Note · Jan 7, 2014 – Feb 25, 2014

Address moved from La Jolla, CA to San Diego, CA — INNOVUS PHARMACEUTICALS, INC.

The people listed on the Jan 7, 2014 filing give La Jolla, CA; on the Feb 25, 2014 filing they give San Diego, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 7, 2014 ↗Form D · Feb 25, 2014 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · May 30, 2012 – Aug 26, 2013

Address moved from Sierra Madre, CA to La Jolla, CA — INNOVUS PHARMACEUTICALS, INC.

The people listed on the May 30, 2012 filing give Sierra Madre, CA; on the Aug 26, 2013 filing they give La Jolla, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · May 30, 2012 ↗Form D · Aug 26, 2013 ↗INNOVUS PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 16 offerings reports sales commissions totalling $354,572; 0 report finder's fees; 1 reports proceeds to related persons totalling $35,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jan 11, 2019 D
INNOVUS PHARMACEUTICALS, INC.
File 021-330234
$354,572$0$0H.C. WAINWRIGHT and CO., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Aug 6, 2015 D
INNOVUS PHARMACEUTICALS, INC.
File 021-245185
$0$0$0
In consideration of Vista Note Amendment, the Company issued 100,000 restricted shares of Common Stock to Vista.
None listed on this filingEDGAR ↗
Aug 6, 2015 D
INNOVUS PHARMACEUTICALS, INC.
File 021-245186
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2014 D
INNOVUS PHARMACEUTICALS, INC.
File 021-212501
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2014 D
INNOVUS PHARMACEUTICALS, INC.
File 021-212502
$0$0$0None listed on this filingEDGAR ↗
Jan 7, 2014 D
INNOVUS PHARMACEUTICALS, INC.
File 021-209397
$0$0$0None listed on this filingEDGAR ↗
Jan 7, 2014 D
INNOVUS PHARMACEUTICALS, INC.
File 021-209398
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2013 D
INNOVUS PHARMACEUTICALS, INC.
File 021-201977
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2013 D
INNOVUS PHARMACEUTICALS, INC.
File 021-201979
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2013 D
INNOVUS PHARMACEUTICALS, INC.
File 021-201980
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2013 D/A
INNOVUS PHARMACEUTICALS, INC.
File 021-201981
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2013 D
INNOVUS PHARMACEUTICALS, INC.
File 021-201875
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2013 D
INNOVUS PHARMACEUTICALS, INC.
File 021-201876
$0$0$0None listed on this filingEDGAR ↗
May 30, 2012 D
INNOVUS PHARMACEUTICALS, INC.
File 021-178985
$0$0$35,000 (est.)None listed on this filingEDGAR ↗
Mar 23, 2012 D
INNOVUS PHARMACEUTICALS, INC.
File 021-175510
$0$0$0
Not applicable
None listed on this filingEDGAR ↗
Mar 18, 2010 D
SEELOS THERAPEUTICS, INC.
File 021-45511
$0$0$0
Approximately $2.6 million of the proceeds was applied to the cancellation of indebtedness. The remaining proceeds from the offering will be used for general working capital.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Henry Esber on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

IP
Pharmaceuticals · group: Innovus

INNOVUS PHARMACEUTICALS, INC.

San Diego, CA · Mar 23, 2012 → Jan 11, 2019 · 16 filings
  • Jan 11, 2019 · D · $3,171,445 sold of $3,171,445 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 6, 2015 · D · $500,000 sold of $1,500,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 6, 2015 · D · $16,000 sold of $16,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 25, 2014 · D · $742,300 sold of $742,300 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 25, 2014 · D · $330,000 sold of $330,000 · 1 investors · min. $300,000 · role: Director EDGAR ↗
  • Jan 7, 2014 · D · $350,000 sold of $350,000 · 1 investors · min. $350,000 · role: Director EDGAR ↗
  • Jan 7, 2014 · D · $0 sold of Indefinite · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2013 · D/A · $50,000 sold of $50,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2013 · D · $50,000 sold of $50,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2013 · D · $174,668 sold of $174,668 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2013 · D · $1,070,000 sold of $1,070,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2013 · D · $50,000 sold of $50,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2013 · D · $4,484,661 sold of $6,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2013 · D · $134,640 sold of $134,640 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 30, 2012 · D · $0 sold of $1,100,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 23, 2012 · D · $0 sold of $0 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $4.48M from 28 investors (100% of the $3.17M target) as of the latest filing. Henry is listed as director on 16 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Biotechnology

SEELOS THERAPEUTICS, INC.

New York, NY · Mar 10, 2010 → Mar 18, 2010 · 2 filings
  • Mar 18, 2010 · D · $4,000,000 sold of $4,000,000 · 3 investors · min. No minimum reported · role: Director, Executive Officer EDGAR ↗
  • Mar 10, 2010 · D · $2,300,000 sold of $2,500,000 · 3 investors · min. No minimum reported · role: Director, Executive Officer EDGAR ↗

Raised $4M from 13 investors (100% of the $4M target) as of the latest filing. Henry is listed as director, executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Henry J. Esber — NH, MA, 3 issuers, Jun 16, 2017 → Nov 5, 2019 · no shared issuer
  • Henry Esber — MA, 1 issuer, Nov 16, 2015 → Sep 5, 2017 · no shared issuer

People around Henry 14

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

VL
No photo found yet (own website and image search run after this page is viewed)
Person

Vivian Liu

Director, Executive Officer · 18 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Henry Esber. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Bassam Damaj

Director, Executive Officer · 16 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Henry Esber. Their page shows their other deals.

ZM
No photo found yet (own website and image search run after this page is viewed)
Person

Ziad Mirza

Director · 15 shared filings (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Morgan Reed Brown

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

Rusty Ray

Director · 2 shared filings (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Cox

Executive Officer · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Henry Esber. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Roberto Crea

Director · 2 shared filings (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Westgate

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Henry Esber. Their page shows their other deals.

LO
No photo found yet (own website and image search run after this page is viewed)
Person

Leonard Oppenheim

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Henry Esber. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

Wallace Boyack

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Berman

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Richard Berman is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Randy Berholtz

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Henry Esber. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ryan Selhorn

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

DN
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Nuhaily

Director · 1 shared filing (1 issuer)

Listed on the same filings as Henry Esber. Their page shows their other deals.

The team behind the deals

I
Sponsor group

Innovus

3 issuers · 21 filings · $3.54M reported sold · 2012–2019

One team, 3 deal companies. Henry Esber is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Henry Esber.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Henry Esber by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Henry Esber is listed on: none on file. No website or social profile named in SEELOS THERAPEUTICS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #93,301 of 374,652 in line (1,376 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (New York, NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗New York WebCivil Supreme ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗New York Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Henry Esber appears on a new Form D, or when a court case or SEC action is matched to them. See plans →